These compounds can (i) minimize SARS-CoV-2 viral infection by attaching to the ACE2 receptor and avoid viral infringement; and (ii) change the magnitude of COVID-19-related lung injury through ACE2 expression (238). Here, ACE2 is linked to COVID-19.